(复方)感冒灵
Search documents
佛山:在药店购买这47种药物须实名登记
Yang Shi Wang· 2025-08-05 01:32
Group 1 - The list includes various common cold and flu medications, indicating a diverse product range in the pharmaceutical market [1][2] - The medications listed are primarily oral formulations, suggesting a focus on ease of administration for consumers [1][2] - The inclusion of children's formulations highlights the industry's attention to pediatric care and market expansion opportunities [1][2] Group 2 - The presence of antiviral medications such as Oseltamivir and Ribavirin indicates a strategic focus on addressing viral infections within the product portfolio [2] - The variety of formulations, including capsules, tablets, and syrups, reflects the industry's adaptability to consumer preferences and needs [2] - The list suggests a competitive landscape with numerous options available for treating cold and flu symptoms, which may impact market dynamics [2]
最新!在佛山药店购买这47种药品,需实名登记
Hua Xia Shi Bao· 2025-08-05 01:05
Core Viewpoint - The article discusses the implementation of a strict registration system for the sale of key controlled drugs in retail pharmacies in Foshan, effective from August 1, as part of the city's pandemic prevention efforts [1][2]. Group 1: Regulatory Changes - The Foshan Market Supervision Administration has mandated that all retail pharmacies in the city must adhere to a registration reporting system for 47 types of key controlled drugs [1]. - The registration system requires customers to provide personal information and undergo a verification process when purchasing specific medications related to symptoms of Chikungunya fever [1]. Group 2: Drug List and Compliance - The controlled drugs include common medications such as (compound) Ganmaoling, Xiao Chai Hu Granules, Lianhua Qingwen Capsules, (compound) Banlangen, Ibuprofen, and others [1]. - Pharmacies are instructed to assist vulnerable groups, such as the elderly, in completing the registration process while ensuring the confidentiality of personal information collected [1]. Group 3: Current Epidemic Situation - Guangdong Province reported 2,892 new local cases of Chikungunya fever from July 27 to August 2, with the majority of cases in Foshan [2]. - The epidemic's upward trend has shown signs of initial containment, particularly in the core area of Shunde, although risks from international cases and environmental factors remain [2].